Technology & Innovation

Oxford’s Eden Research gets go-ahead for biofungicide in Poland

Published by
Daniel Face

Oxford-based sustainable biopesticide firm Eden Research has announced that its flagship biofungicide, Mevalone, has obtained regulatory authorisation in Poland.

This will mean farmers in Poland can apply the product to wine and table grapes to protect and treat outbreaks of Botrytris cinerea and to apples to prevent post-harvest storage diseases.

SumiAgro Europe has been appointed as the exclusive distributor of Mevalone in the territory with product distribution expected to commence imminently. SumiAgro has extensive experience with the fungicide, having previously supported Eden with significantextensions in France.

As the EU’s largest producer of apples, Poland represents a significant market for Eden Research and Mevalone. Eden expects to receive additional regulatory approvals in due course in additional Central European member states such as Germany, Austria, and Hungary, where high levels of wine production are found.

Read more - Eden Research authorised to use flagship biofungicide for home and garden use

Eden CEO Sean Smith said: “Our regulatory approval in Poland marks the beginning of our commercial push into Central Europe, and we are excited by further approvals in the region in due course.

“While the Polish grape market is relatively small when compared with neighbouring Central European countries, we are encouraged by the opportunities that lie within the apples segment for post-harvest storage disease control.

“Pre-harvest application of Mevalone helps to protect produce from diseases that can develop during the long storage period, further demonstrating the versatility within our product offering.

“We are proud to be able to provide farmers with a highly effective crop protection solution that not only supports sustainability in agriculture but also helps to reduce food waste in the supply chain.

“Furthermore, we are delighted to continue our partnership with SumiAgro, a company with significant influence across Central Europe and the ability to gain market share. We expect distribution of our product to commence imminently with meaningful sales to be realised in the upcoming seasons.”

Read more - Oxford Innovation invests in OSSTEC’s bone healing implants

Daniel Face

Born and raised in Berkshire, Dan fell into journalism after completing his bachelor’s degree in English at UCL. Writing for The Business Magazine and local Biz News sites has given him the opportunity to chat with all manner of small business owners and share their success stories with a wider audience. Outside of work, Dan enjoys live music, board games and quiz shows, and is making a slow but persistent effort to learn Spanish.

Recent Posts

Do you know the Young Property Person of the Year?

Though every category at the Thames Valley Property Awards sees a diverse range of entries…

8 mins ago

Baking and British Sign Language courses booming at Warwickshire college

New courses in baking and British Sign Language (BSL) at Royal Leamington Spa College have…

8 hours ago

Bristol’s 9Trees picks up national title at FSB Celebrating Small Business Awards

The Federation of Small Businesses (FSB) has awarded the Micro Business Award to a leading…

8 hours ago

Green light for Allsee Technologies’ Birmingham HQ set to create 150 jobs

Allsee Technologies’ proposed landmark office headquarters and digital technology centre at Longbridge Business Park in…

8 hours ago

Bristol Rovers Community Trust gets show on the road with new luxury minibus

A Bristol community charity has moved into vehicle purchasing for the first time with the…

8 hours ago

Coventry's PLMR Advent makes senior appointment

Coventry-based PR, communications and public affairs agency PLMR Advent has appointed Paul Suart as account…

8 hours ago